Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (374 ops.)
Latest filing published 23 Jun 2026 for UNITED THERAPEUTICS Corp, €941k.
Filing timeline
BuySaleJames Edgemond
First 200 filings with a declared amount
Insider track record
Disclosed buys
0
Disclosed sells
374
Signal history
James Edgemond: trading record in brief
James Edgemond filed 374 sales at UNITED THERAPEUTICS Corp, worth EUR 199,981,371 in total with a median of EUR 358,272. Two of them fall on the same day, May 15, 2024: EUR 6,260,213 and EUR 3,796,193. Another, EUR 3,124,050, dates from December 1, 2025. No purchase appears.
The 463 filings, published from November 9, 2022 to June 23, 2026, come from this single issuer, under the title CFO AND TREASURER. They include 85 option exercises, 2 share grants and 2 filings of another kind. Annual volume is very concentrated: 4 filings in 2022, 100 in 2024, 93 in 2025 and 266 in 2026. In the last twelve months, 348 filings fall, 315 of them sales.
Filings appear a median of 1 day after the trade, across 463 dated filings. At United Therapeutics, Martine A. Rothblatt has 331 open-market trades within 30 days of those of Edgemond, Paul A. Mahon 268, Christopher Patusky 247, Christopher Causey and Jan Malcolm 197, all in the same direction.
Companies and markets linked to James Edgemond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations463 total
1,994 shares@ US$539.13010.7% of flowCommon StockSEC:0001636178-26-000029:6
2,266 shares@ US$538.2340.8% of flowCommon StockSEC:0001636178-26-000029:5
164 shares@ US$534.05950.1% of flowCommon StockSEC:0001636178-26-000029:1
8,750 sharesCommon StockSEC:0001636178-26-000029:0
865 shares@ US$534.98490.3% of flowCommon StockSEC:0001636178-26-000029:2
1,091 shares@ US$536.04660.4% of flowCommon StockSEC:0001636178-26-000029:3
840 shares@ US$537.18290.3% of flowCommon StockSEC:0001636178-26-000029:4
280 shares@ US$539.82610.1% of flowCommon StockSEC:0001636178-26-000029:7
1,250 shares@ US$541.250.4% of flowCommon StockSEC:0001636178-26-000029:8
2,978 shares@ US$540.21751.0% of flowCommon StockSEC:0001636178-26-000028:7
115 shares@ US$547.80520.0% of flowCommon StockSEC:0001636178-26-000028:13
1,440 shares@ US$538.30790.5% of flowCommon StockSEC:0001636178-26-000028:5
192 shares@ US$541.88460.1% of flowCommon StockSEC:0001636178-26-000028:9
600 shares@ US$537.23970.2% of flowCommon StockSEC:0001636178-26-000028:4
660 shares@ US$548.90210.2% of flowCommon StockSEC:0001636178-26-000028:14
160 shares@ US$534.4750.1% of flowCommon StockSEC:0001636178-26-000028:2
265 shares@ US$547.36830.1% of flowCommon StockSEC:0001636178-26-000028:12
40 shares@ US$545.190.0% of flowCommon StockSEC:0001636178-26-000028:11
210 shares@ US$536.27210.1% of flowCommon StockSEC:0001636178-26-000028:3
2,035 shares@ US$539.41730.7% of flowCommon StockSEC:0001636178-26-000028:6
865 shares@ US$541.05820.3% of flowCommon StockSEC:0001636178-26-000028:8
400 shares@ US$533.5870.1% of flowCommon StockSEC:0001636178-26-000028:1
40 shares@ US$543.52680.0% of flowCommon StockSEC:0001636178-26-000028:10
10,000 sharesCommon StockSEC:0001636178-26-000028:0
855 shares@ US$545.63440.3% of flowCommon StockSEC:0001636178-26-000027:6
25 of 463 declarations
